Psyllid ID: psy15368

Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520--
MGKLLLISFLLLFLLDLVRGTLLYNSNFTDPSLDFLNDTFNGTACPHSTGPTLFFATQTIYLIICITGLLGNTLVIYVVLRFSKMQTVTNMYIVNLAIADECFLIGIPFLMITIKMQTVTNMYIVNLAIADECFLIGIPFLMITMSISYWHYILVSLFRVASLSSYWPFGDLMCKIYMTTTSINQFTSSIFLTIMSADRYVAVCHPITAPNLRTPFISKVVSFIAWTASAIFMIPVIMYASIIDSENTKSCNIMWPETENLNGQSAFILYTFILGFAIPLVLIFVFYYLVIRKLRTVGPKNKPKEKKKSHRKVTKLVLTVITLRTVGPKNKPKEKKKSHRKVTKLVLTVITVYVLCWLPYWITQIALIFTPPRQCQSSITVIVFLIAGALSYSNSAMNPILYAFLSDNFKKSFLKACTCAAGKDVNATLHLENSVTCLNSVFPRKRNSERYHTRPRGAATSSRPDEECNEIGSRGGQSTTALTSRSNITMSTDSGVAMGTKDQFSNGLGTNTNGNSMIATTV
ccccHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHccEEEEEEEEEccccccHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHEEccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHEEEEccccccEEEcccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHEEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHHHcHHHHHHHHccccHHHHHHHHHcccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
cccEEEHHHHHHHHccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcHEEEEEHHcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccHEccHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHHEHHEHHHEEEEEccccccccccHHHHHHHHHHHHHHHHHHHccHHHccccccccccEEccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccHHHHHHHHccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHHHccccEEEEcccHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHcccccccccccEEEEEc
MGKLLLISFLLLFLLDLVRGtllynsnftdpsldflndtfngtacphstgptlffaTQTIYLIICITGLLGNTLVIYVVLRFSKMQTVTNMYIVNLAIADECFLIGIPFLMITIKMQTVTNMYIVNLAIADECFLIGIPFLMITMSISYWHYILVSLFRVAslssywpfgdlMCKIYMTTTSINQFTSSIFLTIMSADRYVAVchpitapnlrtpfISKVVSFIAWTASAIFMIPVIMYASiidsentkscnimwpetenlngqsAFILYTFILGFAIPLVLIFVFYYLVIRKLRtvgpknkpkekkkshrKVTKLVLTVITLrtvgpknkpkekkkshrKVTKLVLTVITVYVLCWLPYWITQIALiftpprqcqssITVIVFLIAGALsysnsamnpILYAFLSDNFKKSFLKACTCAAGKDVNATLHLENSVTClnsvfprkrnseryhtrprgaatssrpdeecneigsrggqsttaltsrsnitmstdsgvamgtkdqfsnglgtntngnsMIATTV
MGKLLLISFLLLFLLDLVRGTLLYNSNFTDPSLDFLNDTFNGTACPHSTGPTLFFATQTIYLIICITGLLGNTLVIYVVLRFSKMQTVTNMYIVNLAIADECFLIGIPFLMITIKMQTVTNMYIVNLAIADECFLIGIPFLMITMSISYWHYILVSLFRVASLSSYWPFGDLMCKIYMTTTSINQFTSSIFLTIMSADRYVAVCHPITAPNLRTPFISKVVSFIAWTASAIFMIPVIMYASIIDSENTKSCNIMWPETENLNGQSAFILYTFILGFAIPLVLIFVFYYLVIRKLrtvgpknkpkekkkshrkvtklvltvitlrtvgpknkpkekkkshrkvtklVLTVITVYVLCWLPYWITQIALIFTPPRQCQSSITVIVFLIAGALSYSNSAMNPILYAFLSDNFKKSFLKACTCAAGKDVnatlhlensvtclnsvfprkrnseryhtrprgaatssrpdeecneigsrggqsttaltsrsnITMSTDSGVAMGTKDqfsnglgtntngnsmiattv
MGKlllisflllflldlvrgtllYNSNFTDPSLDFLNDTFNGTACPHSTGPTLFFATQTIYLIICITGLLGNTLVIYVVLRFSKMQTVTNMYIVNLAIADECFLIGIPFLMITIKMQTVTNMYIVNLAIADECFLIGIPFLMITMSISYWHYILVSLFRVASLSSYWPFGDLMCKIYMTTTSINQFTSSIFLTIMSADRYVAVCHPITAPNLRTPFISKVVSFIAWTASAIFMIPVIMYASIIDSENTKSCNIMWPETENLNGQSAFILYTFILGFAIPLVLIFVFYYLVIRKLRTVGPknkpkekkkshrkVTKLVLTVITLRTVGPknkpkekkkshrkvtklvltvitvyvlCWLPYWITQIALIFTPPRQCQSSITVIVFLIAGALSYSNSAMNPILYAFLSDNFKKSFLKACTCAAGKDVNATLHLENSVTCLNSVFPRKRNSERYHTRPRGAATSSRPDEECNEIGSRGGQSTTALTSRSNITMSTDSGVAMGTKDQFSnglgtntngnSMIATTV
***LLLISFLLLFLLDLVRGTLLYNSNFTDPSLDFLNDTFNGTACPHSTGPTLFFATQTIYLIICITGLLGNTLVIYVVLRFSKMQTVTNMYIVNLAIADECFLIGIPFLMITIKMQTVTNMYIVNLAIADECFLIGIPFLMITMSISYWHYILVSLFRVASLSSYWPFGDLMCKIYMTTTSINQFTSSIFLTIMSADRYVAVCHPITAPNLRTPFISKVVSFIAWTASAIFMIPVIMYASIIDSENTKSCNIMWPETENLNGQSAFILYTFILGFAIPLVLIFVFYYLVIRKLRT*****************TKLVLTVITLRT****************VTKLVLTVITVYVLCWLPYWITQIALIFTPPRQCQSSITVIVFLIAGALSYSNSAMNPILYAFLSDNFKKSFLKACTCAAGKDVNATLHLENSVTCLNSVF********************************************************************************
****LLISFLLLFLLDLVRGTLLYNSNFTDPSLDFLNDTFNGTACPHSTGPTLFFATQTIYLIICITGLLGNTLVIYVVLRFSKMQTVTNMYIVNLAIADECFLIGIPFLMITIKMQTVTNMYIVNLAIADECFLIGIPFLMITMSISYWHYILVSLFRVASLSSYWPFGDLMCKIYMTTTSINQFTSSIFLTIMSADRYVAVCHPITAPNLRTPFISKVVSFIAWTASAIFMIPVIMYASIIDSENTKSCNIMWPETENLNGQSAFILYTFILGFAIPLVLIFVFYYLVIRKLR**********************************************VTKLVLTVITVYVLCWLPYWITQIALIFTPPRQCQSSITVIVFLIAGALSYSNSAMNPILYAFLSDNFKKSFLKACTC*******************************************************************************************************
MGKLLLISFLLLFLLDLVRGTLLYNSNFTDPSLDFLNDTFNGTACPHSTGPTLFFATQTIYLIICITGLLGNTLVIYVVLRFSKMQTVTNMYIVNLAIADECFLIGIPFLMITIKMQTVTNMYIVNLAIADECFLIGIPFLMITMSISYWHYILVSLFRVASLSSYWPFGDLMCKIYMTTTSINQFTSSIFLTIMSADRYVAVCHPITAPNLRTPFISKVVSFIAWTASAIFMIPVIMYASIIDSENTKSCNIMWPETENLNGQSAFILYTFILGFAIPLVLIFVFYYLVIRKLRTVGP*************VTKLVLTVITLRTVGP*************VTKLVLTVITVYVLCWLPYWITQIALIFTPPRQCQSSITVIVFLIAGALSYSNSAMNPILYAFLSDNFKKSFLKACTCAAGKDVNATLHLENSVTCLNSVFPRKRN*********************************ALTSRSNITMSTDSGVAMGTKDQFSNGLGTNTNGNSMIATTV
*GKLLLISFLLLFLLDLVRGT***************************TGPTLFFATQTIYLIICITGLLGNTLVIYVVLRFSKMQTVTNMYIVNLAIADECFLIGIPFLMITIKMQTVTNMYIVNLAIADECFLIGIPFLMITMSISYWHYILVSLFRVASLSSYWPFGDLMCKIYMTTTSINQFTSSIFLTIMSADRYVAVCHPITAPNLRTPFISKVVSFIAWTASAIFMIPVIMYASIIDSENTKSCNIMWPETENLNGQSAFILYTFILGFAIPLVLIFVFYYLVIRKLRTVGPKNKPKE**************************PKEKKKSHRKVTKLVLTVITVYVLCWLPYWITQIALIFTPPRQCQSSITVIVFLIAGALSYSNSAMNPILYAFLSDNFKKSFLKACTCAAG****************************************************************************GTKDQFSNGLGTNTNGNSMIATTV
iiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
oooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
oooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
oooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
SSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
SSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MGKLLLISFLLLFLLDLVRGTLLYNSNFTDPSLDFLNDTFNGTACPHSTGPTLFFATQTIYLIICITGLLGNTLVIYVVLRFSKMQTVTNMYIVNLAIADECFLIGIPFLMITIKMQTVTNMYIVNLAIADECFLIGIPFLMITMSISYWHYILVSLFRVASLSSYWPFGDLMCKIYMTTTSINQFTSSIFLTIMSADRYVAVCHPITAPNLRTPFISKVVSFIAWTASAIFMIPVIMYASIIDSENTKSCNIMWPETENLNGQSAFILYTFILGFAIPLVLIFVFYYLVIRKLRTVGPKNKPKEKKKSHRKVTKLVLTVITLRTVGPKNKPKEKKKSHRKVTKLVLTVITVYVLCWLPYWITQIALIFTPPRQCQSSITVIVFLIAGALSYSNSAMNPILYAFLSDNFKKSFLKACTCAAGKDVNATLHLENSVTCLNSVFPRKRNSERYHTRPRGAATSSRPDEECNEIGSRGGQSTTALTSRSNITMSTDSGVAMGTKDQFSNGLGTNTNGNSMIATTV
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

Original result of BLAST against SWISS-PROT Database

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query522 2.2.26 [Sep-21-2011]
P35346364 Somatostatin receptor typ yes N/A 0.536 0.769 0.348 9e-54
P30874369 Somatostatin receptor typ no N/A 0.519 0.734 0.357 3e-53
P30937384 Somatostatin receptor typ yes N/A 0.540 0.734 0.308 7e-53
P49660384 Somatostatin receptor typ yes N/A 0.540 0.734 0.310 7e-53
F1MV99368 Somatostatin receptor typ yes N/A 0.536 0.760 0.356 5e-52
P28646391 Somatostatin receptor typ no N/A 0.557 0.744 0.328 2e-51
P30873391 Somatostatin receptor typ no N/A 0.557 0.744 0.328 2e-51
P30872391 Somatostatin receptor typ no N/A 0.603 0.805 0.322 2e-51
Q49LX5391 Somatostatin receptor typ no N/A 0.603 0.805 0.322 2e-51
P34993368 Somatostatin receptor typ no N/A 0.565 0.801 0.341 4e-51
>sp|P35346|SSR5_HUMAN Somatostatin receptor type 5 OS=Homo sapiens GN=SSTR5 PE=1 SV=3 Back     alignment and function desciption
 Score =  211 bits (538), Expect = 9e-54,   Method: Compositional matrix adjust.
 Identities = 128/367 (34%), Positives = 189/367 (51%), Gaps = 87/367 (23%)

Query: 65  CITGLLGNTLVIYVVLRFSKMQTVTNMYIVNLAIADECFLIGIPFLMITIKMQTVTNMYI 124
           C  GL GNTLVIYVVLRF+KM+TVTN+YI+NLA+AD  +++G+PFL              
Sbjct: 51  CAAGLGGNTLVIYVVLRFAKMKTVTNIYILNLAVADVLYMLGLPFLATQ----------- 99

Query: 125 VNLAIADECFLIGIPFLMITMSISYWHYILVSLFRVASLSSYWPFGDLMCKIYMTTTSIN 184
                                                + +S+WPFG ++C++ MT   +N
Sbjct: 100 -------------------------------------NAASFWPFGPVLCRLVMTLDGVN 122

Query: 185 QFTSSIFLTIMSADRYVAVCHPITAPNLRTPFISKVVSFIAWTASAIFMIPVIMYASIID 244
           QFTS   LT+MS DRY+AV HP+++   R P ++K+ S  AW  S    +P++++A   D
Sbjct: 123 QFTSVFCLTVMSVDRYLAVVHPLSSARWRRPRVAKLASAAAWVLSLCMSLPLLVFA---D 179

Query: 245 SENTKSCNIMWPETENLNGQSAFILYTFILGFAIPLVLIFVFYYLVIRKLRTVGPKNKPK 304
            +   +CN  WPE   L G + FI+YT +LGF  PL++I + Y L++ K+R  G +    
Sbjct: 180 VQEGGTCNASWPEPVGLWG-AVFIIYTAVLGFFAPLLVICLCYLLIVVKVRAAGVRVG-C 237

Query: 305 EKKKSHRKVTKLVLTVITLRTVGPKNKPKEKKKSHRKVTKLVLTVITVYVLCWLPYWITQ 364
            +++S RKV                             T++VL V+ V+  CWLP++   
Sbjct: 238 VRRRSERKV-----------------------------TRMVLVVVLVFAGCWLPFFTVN 268

Query: 365 IALIFTPPRQCQSSITVIVFLIAGALSYSNSAMNPILYAFLSDNFKKSFLKACTCAAG-- 422
           I  +     Q  +S  +  F++   LSY+NS  NP+LY FLSDNF++SF K      G  
Sbjct: 269 IVNLAVALPQEPASAGLYFFVV--ILSYANSCANPVLYGFLSDNFRQSFQKVLCLRKGSG 326

Query: 423 -KDVNAT 428
            KD +AT
Sbjct: 327 AKDADAT 333
Receptor for somatostatin 28 and to a lesser extent for somatostatin-14. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase.
Homo sapiens (taxid: 9606)
>sp|P30874|SSR2_HUMAN Somatostatin receptor type 2 OS=Homo sapiens GN=SSTR2 PE=1 SV=1 Back     alignment and function description
>sp|P30937|SSR4_RAT Somatostatin receptor type 4 OS=Rattus norvegicus GN=Sstr4 PE=2 SV=1 Back     alignment and function description
>sp|P49660|SSR4_MOUSE Somatostatin receptor type 4 OS=Mus musculus GN=Sstr4 PE=2 SV=1 Back     alignment and function description
>sp|F1MV99|SSR5_BOVIN Somatostatin receptor type 5 OS=Bos taurus GN=SSTR5 PE=3 SV=2 Back     alignment and function description
>sp|P28646|SSR1_RAT Somatostatin receptor type 1 OS=Rattus norvegicus GN=Sstr1 PE=2 SV=1 Back     alignment and function description
>sp|P30873|SSR1_MOUSE Somatostatin receptor type 1 OS=Mus musculus GN=Sstr1 PE=2 SV=1 Back     alignment and function description
>sp|P30872|SSR1_HUMAN Somatostatin receptor type 1 OS=Homo sapiens GN=SSTR1 PE=1 SV=1 Back     alignment and function description
>sp|Q49LX5|SSR1_CANFA Somatostatin receptor type 1 OS=Canis familiaris GN=SSTR1 PE=3 SV=1 Back     alignment and function description
>sp|P34993|SSR2_BOVIN Somatostatin receptor type 2 OS=Bos taurus GN=SSTR2 PE=2 SV=1 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

Original result of BLAST against Nonredundant Database

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query522
357602698417 neuropeptide receptor A1 [Danaus plexipp 0.703 0.880 0.550 1e-131
340711663424 PREDICTED: somatostatin receptor type 4- 0.649 0.799 0.583 1e-130
350402360546 PREDICTED: somatostatin receptor type 2- 0.664 0.635 0.575 1e-129
380029917425 PREDICTED: somatostatin receptor type 4- 0.712 0.875 0.556 1e-128
328717227448 PREDICTED: somatostatin receptor type 2- 0.626 0.729 0.583 1e-128
48112653423 PREDICTED: somatostatin receptor type 4- 0.710 0.877 0.557 1e-128
383862095421 PREDICTED: somatostatin receptor type 2- 0.710 0.881 0.557 1e-127
307182435422 Somatostatin receptor type 2 [Camponotus 0.737 0.912 0.543 1e-127
307200388420 Somatostatin receptor type 1 [Harpegnath 0.743 0.923 0.542 1e-126
156553863423 PREDICTED: somatostatin receptor type 2- 0.649 0.801 0.570 1e-126
>gi|357602698|gb|EHJ63490.1| neuropeptide receptor A1 [Danaus plexippus] Back     alignment and taxonomy information
 Score =  475 bits (1223), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 249/452 (55%), Positives = 291/452 (64%), Gaps = 85/452 (18%)

Query: 37  NDTFNGT--ACPHSTGPTLFFATQTIYLIICITGLLGNTLVIYVVLRFSKMQTVTNMYIV 94
           N TFNGT   CP+   P +   TQ +Y ++C+ GLLGNTLVIYVVLR+SKMQT       
Sbjct: 19  NGTFNGTYENCPNINLPIVSVVTQILYALVCVIGLLGNTLVIYVVLRYSKMQT------- 71

Query: 95  NLAIADECFLIGIPFLMITIKMQTVTNMYIVNLAIADECFLIGIPFLMITMSISYWHYIL 154
                                   VTNMYIVNLAIADECFLIGIPFL++TMS+  W    
Sbjct: 72  ------------------------VTNMYIVNLAIADECFLIGIPFLIVTMSLRSW---- 103

Query: 155 VSLFRVASLSSYWPFGDLMCKIYMTTTSINQFTSSIFLTIMSADRYVAVCHPITAPNLRT 214
                        PFG  MCK YM +T INQFTSSIFL IMSADRY+AVCHPI AP LRT
Sbjct: 104 -------------PFGSFMCKAYMISTGINQFTSSIFLCIMSADRYIAVCHPIAAPRLRT 150

Query: 215 PFISKVVSFIAWTASAIFMIPVIMYASIIDSENTKSCNIMWPETENLNGQSAFILYTFIL 274
           PF+S+VVS  AWTASA+ M P+ MY ++I +EN+ SCNI+WPE E   GQ++F LY+  L
Sbjct: 151 PFVSRVVSAAAWTASALVMAPIFMYTTLIKTENSLSCNIVWPEKEFNKGQTSFTLYSLAL 210

Query: 275 GFAIPLVLIFVFYYLVIRKLRTVGPKNKPKEKKKSHRKVTKLVLTVITLRTVGPKNKPKE 334
           GFA PL LIFVFY LVIRKL+TVGPKNK KEKK+SHRKVTK                   
Sbjct: 211 GFAAPLTLIFVFYCLVIRKLKTVGPKNKSKEKKRSHRKVTK------------------- 251

Query: 335 KKKSHRKVTKLVLTVITVYVLCWLPYWITQIALIFTPPRQCQSSITVIVFLIAGALSYSN 394
                     LVLTVI VYVLCWLPYW  Q+ALI++PP +C S IT+ VFL+A   SYSN
Sbjct: 252 ----------LVLTVIAVYVLCWLPYWAFQVALIYSPPTECASRITITVFLVAACFSYSN 301

Query: 395 SAMNPILYAFLSDNFKKSFLKACTCAAGKDVNATLHLENSVTCLNSVFPRKRNSERYHTR 454
           SAMNPILYAFLSDNFKKSFLKACTCAAGKDVNATLH+E      NS+ PRK+       +
Sbjct: 302 SAMNPILYAFLSDNFKKSFLKACTCAAGKDVNATLHVE------NSMIPRKKGGSAARAQ 355

Query: 455 PRGAATSSRPDEECNEIGSRGGQSTTALTSRS 486
            R  A +       +  G    +++TA+TSRS
Sbjct: 356 SRALAEARGLSAHADGPGGSRSEASTAITSRS 387

Source: Danaus plexippus

Species: Danaus plexippus

Genus: Danaus

Family: Nymphalidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota
>gi|340711663|ref|XP_003394391.1| PREDICTED: somatostatin receptor type 4-like [Bombus terrestris] Back     alignment and taxonomy information
>gi|350402360|ref|XP_003486456.1| PREDICTED: somatostatin receptor type 2-like [Bombus impatiens] Back     alignment and taxonomy information
>gi|380029917|ref|XP_003698610.1| PREDICTED: somatostatin receptor type 4-like [Apis florea] Back     alignment and taxonomy information
>gi|328717227|ref|XP_001950448.2| PREDICTED: somatostatin receptor type 2-like isoform 1 [Acyrthosiphon pisum] gi|328717229|ref|XP_003246151.1| PREDICTED: somatostatin receptor type 2-like isoform 2 [Acyrthosiphon pisum] Back     alignment and taxonomy information
>gi|48112653|ref|XP_396335.1| PREDICTED: somatostatin receptor type 4-like [Apis mellifera] Back     alignment and taxonomy information
>gi|383862095|ref|XP_003706519.1| PREDICTED: somatostatin receptor type 2-like [Megachile rotundata] Back     alignment and taxonomy information
>gi|307182435|gb|EFN69671.1| Somatostatin receptor type 2 [Camponotus floridanus] Back     alignment and taxonomy information
>gi|307200388|gb|EFN80627.1| Somatostatin receptor type 1 [Harpegnathos saltator] Back     alignment and taxonomy information
>gi|156553863|ref|XP_001600654.1| PREDICTED: somatostatin receptor type 2-like [Nasonia vitripennis] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

Original result of BLAST against Gene Ontology (AMIGO)

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query522
FB|FBgn0036790483 star1 "allatostatin C receptor 0.300 0.325 0.577 6e-70
UNIPROTKB|F1NJP5370 SSTR5 "Uncharacterized protein 0.298 0.421 0.383 4.3e-63
UNIPROTKB|Q58G83359 SS5R "Uncharacterized protein" 0.298 0.434 0.383 4.3e-63
ZFIN|ZDB-GENE-040426-2502383 zgc:85682 "zgc:85682" [Danio r 0.342 0.467 0.360 4.8e-62
MGI|MGI:894282362 Sstr5 "somatostatin receptor 5 0.295 0.425 0.382 4.2e-61
UNIPROTKB|Q58G84371 SS2R "Uncharacterized protein" 0.300 0.423 0.373 5.3e-61
UNIPROTKB|P30874369 SSTR2 "Somatostatin receptor t 0.300 0.425 0.371 2.6e-60
UNIPROTKB|F1PMH8332 SSTR2 "Somatostatin receptor t 0.300 0.472 0.377 6.8e-60
UNIPROTKB|F1MV99368 SSTR5 "Somatostatin receptor t 0.293 0.415 0.407 7.5e-60
UNIPROTKB|F1Q451365 SSTR5 "Uncharacterized protein 0.296 0.424 0.396 9.6e-60
FB|FBgn0036790 star1 "allatostatin C receptor 1" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
 Score = 467 (169.5 bits), Expect = 6.0e-70, Sum P(2) = 6.0e-70
 Identities = 93/161 (57%), Positives = 113/161 (70%)

Query:   167 WPFGDLMCKIYMTTTSINQFTSSIFLTIMSADRYVAVCHPITAPNLRTPFISKVVSFIAW 226
             W FG+ MCK YM +TSI  FTSSIFL IMSADRY+AVCHPI++P  RT  I+KVVS IAW
Sbjct:   142 WRFGEFMCKAYMVSTSITSFTSSIFLLIMSADRYIAVCHPISSPRYRTLHIAKVVSAIAW 201

Query:   227 TASAIFMIPVIMYASIIDSEN--TKSCNIMWPETENLNGQSAFILYTFILGFAIPLVLIF 284
             + SA+ M+PVI+YAS ++ E+    SCNIMWP+    +  + FILYTF LGFA PL  I 
Sbjct:   202 STSAVLMLPVILYASTVEQEDGINYSCNIMWPDAYKKHSGTTFILYTFFLGFATPLCFIL 261

Query:   285 VFYYLVIRKLRTVGPX--XXXXXXXXXXXXVTKLVLTVITL 323
              FYYLVIRKLR+VGP               VT+LVLTVI++
Sbjct:   262 SFYYLVIRKLRSVGPKPGTKSKEKRRAHRKVTRLVLTVISV 302
GO:0016021 "integral to membrane" evidence=IEA;ISS;NAS
GO:0007186 "G-protein coupled receptor signaling pathway" evidence=IEA;ISS;NAS
GO:0004994 "somatostatin receptor activity" evidence=IEA;ISS
GO:0008188 "neuropeptide receptor activity" evidence=ISS
GO:0008261 "allatostatin receptor activity" evidence=NAS;IDA
UNIPROTKB|F1NJP5 SSTR5 "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
UNIPROTKB|Q58G83 SS5R "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
ZFIN|ZDB-GENE-040426-2502 zgc:85682 "zgc:85682" [Danio rerio (taxid:7955)] Back     alignment and assigned GO terms
MGI|MGI:894282 Sstr5 "somatostatin receptor 5" [Mus musculus (taxid:10090)] Back     alignment and assigned GO terms
UNIPROTKB|Q58G84 SS2R "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
UNIPROTKB|P30874 SSTR2 "Somatostatin receptor type 2" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
UNIPROTKB|F1PMH8 SSTR2 "Somatostatin receptor type 2" [Canis lupus familiaris (taxid:9615)] Back     alignment and assigned GO terms
UNIPROTKB|F1MV99 SSTR5 "Somatostatin receptor type 5" [Bos taurus (taxid:9913)] Back     alignment and assigned GO terms
UNIPROTKB|F1Q451 SSTR5 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by EFICAz Software ?

No EC number assignment, probably not an enzyme!

Prediction of Functionally Associated Proteins

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

Original result of RPS-BLAST against CDD database

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query522
pfam00001251 pfam00001, 7tm_1, 7 transmembrane receptor (rhodop 2e-48
PHA03087335 PHA03087, PHA03087, G protein-coupled chemokine re 2e-25
PHA02638417 PHA02638, PHA02638, CC chemokine receptor-like pro 1e-14
PHA02834323 PHA02834, PHA02834, chemokine receptor-like protei 2e-11
>gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) Back     alignment and domain information 
 Score =  167 bits (426), Expect = 2e-48
 Identities = 83/292 (28%), Positives = 140/292 (47%), Gaps = 48/292 (16%)

Query: 113 TIKMQTVTNMYIVNLAIADECFLIGIPFLMITMSISYWHYILVSLFRVASLSSYWPFGDL 172
           T K++T TN++++NLA+AD  FL+ +P   +                   +   WPFGD 
Sbjct: 6   TKKLRTPTNIFLLNLAVADLLFLLTLPPWALY----------------YLVGGDWPFGDA 49

Query: 173 MCKIYMTTTSINQFTSSIFLTIMSADRYVAVCHPITAPNLRTPFISKVVSFIAWTASAIF 232
           +CK+      +N + S + LT +S DRY+A+ HP+    +RTP  +KV+  + W  + + 
Sbjct: 50  LCKLVGFLFVVNGYASILLLTAISIDRYLAIVHPLRYRRIRTPRRAKVLILVVWVLALLL 109

Query: 233 MIPVIMYASIIDSENTK--SCNIMWPETENLNGQSAFILYTFILGFAIPLVLIFVFYYLV 290
            +P ++++ +   E     +C I +PE    + + ++ L + +LGF +PL++I V Y L+
Sbjct: 110 SLPPLLFSWLRTVEEGNVTTCLIDFPE---ESTKRSYTLLSTLLGFVLPLLVILVCYTLI 166

Query: 291 IRKLRTVGPKNKPKEKKKSHRKVTKLVLTVITLRTVGPKNKPKEKKKSHRKVTKLVLTVI 350
           +R LR                            R+   + + K      RK  K++L V+
Sbjct: 167 LRTLR-------------------------KRARSGASQARAKRSSSKERKAAKMLLVVV 201

Query: 351 TVYVLCWLPYWITQIALIFTPPRQCQSSITVIVFLIAGALSYSNSAMNPILY 402
            V+VLCWLPY I  +     P       +     LI   L+Y NS +NPI+Y
Sbjct: 202 VVFVLCWLPYHIVLLLDSLCPL--SIWRLLPTALLITLWLAYVNSCLNPIIY 251

This family contains, amongst other G-protein-coupled receptors (GCPRs), members of the opsin family, which have been considered to be typical members of the rhodopsin superfamily. They share several motifs, mainly the seven transmembrane helices, GCPRs of the rhodopsin superfamily. All opsins bind a chromophore, such as 11-cis-retinal. The function of most opsins other than the photoisomerases is split into two steps: light absorption and G-protein activation. Photoisomerases, on the other hand, are not coupled to G-proteins - they are thought to generate and supply the chromophore that is used by visual opsins. Length = 251
>gnl|CDD|222976 PHA03087, PHA03087, G protein-coupled chemokine receptor-like protein; Provisional Back     alignment and domain information
>gnl|CDD|165021 PHA02638, PHA02638, CC chemokine receptor-like protein; Provisional Back     alignment and domain information
>gnl|CDD|165177 PHA02834, PHA02834, chemokine receptor-like protein; Provisional Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

Original result of HHsearch against CDD database

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 522
KOG4219|consensus423 100.0
PHA03234338 DNA packaging protein UL33; Provisional 100.0
PHA03235409 DNA packaging protein UL33; Provisional 100.0
KOG4220|consensus503 100.0
PHA02834323 chemokine receptor-like protein; Provisional 100.0
PHA02638417 CC chemokine receptor-like protein; Provisional 100.0
PHA03087335 G protein-coupled chemokine receptor-like protein; 100.0
PF00001257 7tm_1: 7 transmembrane receptor (rhodopsin family) 100.0
KOG2087|consensus363 99.93
PF10324318 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemorecept 99.87
PF10320257 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemorecep 99.87
PF10328274 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemorecept 99.79
PF10323283 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemorecept 99.63
PF05462303 Dicty_CAR: Slime mold cyclic AMP receptor 99.6
PF05296303 TAS2R: Mammalian taste receptor protein (TAS2R); I 99.57
PF10321313 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemorecept 99.54
PF10317292 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemorecept 99.11
KOG4193|consensus610 98.89
PF03402265 V1R: Vomeronasal organ pheromone receptor family, 98.87
PF11710201 Git3: G protein-coupled glucose receptor regulatin 98.79
PF10292324 7TM_GPCR_Srab: Serpentine type 7TM GPCR receptor c 98.77
PF02101405 Ocular_alb: Ocular albinism type 1 protein; InterP 98.74
PF02118275 Srg: Srg family chemoreceptor; InterPro: IPR000609 98.71
PF10318302 7TM_GPCR_Srh: Serpentine type 7TM GPCR chemorecept 98.51
PF10327303 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemorecept 98.5
PF10326307 7TM_GPCR_Str: Serpentine type 7TM GPCR chemorecept 98.42
KOG4564|consensus473 98.41
PF10316273 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemorecep 98.31
PF04789305 DUF621: Protein of unknown function (DUF621); Inte 98.16
PF10319310 7TM_GPCR_Srj: Serpentine type 7TM GPCR chemorecept 98.16
PF00002242 7tm_2: 7 transmembrane receptor (Secretin family); 98.14
PF03125365 Sre: C. elegans Sre G protein-coupled chemorecepto 97.91
PF02117328 7TM_GPCR_Sra: Serpentine type 7TM GPCR chemorecept 97.86
PF01534328 Frizzled: Frizzled/Smoothened family membrane regi 97.27
PF10322307 7TM_GPCR_Sru: Serpentine type 7TM GPCR chemorecept 96.82
PF1197076 Git3_C: G protein-coupled glucose receptor regulat 96.27
KOG4289|consensus2531 96.02
PF02076283 STE3: Pheromone A receptor; InterPro: IPR001499 G- 95.76
PF06681226 DUF1182: Protein of unknown function (DUF1182); In 94.83
PF03383153 Serpentine_r_xa: Caenorhabditis serpentine recepto 92.38
PF02175236 7TM_GPCR_Srb: Serpentine type 7TM GPCR chemorecept 92.05
KOG4220|consensus 503 80.49
>KOG4219|consensus Back     alignment and domain information 
Probab=100.00  E-value=1.3e-47  Score=356.29  Aligned_cols=298  Identities=25%  Similarity=0.479  Sum_probs=251.2

Q ss_pred             CCCCchHHHHHHHHHHHHHHHhhhhHHHHHHhhhccccccchhhHHHHHhhhhhhhhh-ccchhheehhhccchhhhhhh
Q psy15368         48 STGPTLFFATQTIYLIICITGLLGNTLVIYVVLRFSKMQTVTNMYIVNLAIADECFLI-GIPFLMITIKMQTVTNMYIVN  126 (522)
Q Consensus        48 ~~~~~~~~~~~~i~~ii~~~giigN~lvi~vi~~~~~lr~~~~~~l~~LaiaDll~~l-~~p~~~~~~~~~~~~~~~~~~  126 (522)
                      ........+.++++.++.+++++||.+|++++..+|++|+.+|++|+|||+||++.++ ..++..               
T Consensus        29 ~lp~~~~~~wai~yg~l~~vAv~GN~iVlwIil~hrrMRtvtnyfL~NLAfADl~~s~Fn~~f~f---------------   93 (423)
T KOG4219|consen   29 VLPAWQQALWAIAYGLLVFVAVVGNLIVLWIILAHRRMRTVTNYFLVNLAFADLSMSIFNTVFNF---------------   93 (423)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhcCceEEEEEeehhehhhhHHHHHHHHHHHHHHHHHHhhHHHH---------------
Confidence            3345677889999999999999999999999999999999999999999999999754 455444               


Q ss_pred             hhhhhhhhhhcccceeeehhhhhhhHHhhhHhhhcccCCccccccccchhhhhhhhHHHHHHHHHHHHHHHHHHHHhhhc
Q psy15368        127 LAIADECFLIGIPFLMITMSISYWHYILVSLFRVASLSSYWPFGDLMCKIYMTTTSINQFTSSIFLTIMSADRYVAVCHP  206 (522)
Q Consensus       127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~~~~~~s~~~l~~isidRy~aI~~P  206 (522)
                                                       .+.+...|.+|...|++..|+..+...+|++++++||+|||+||.||
T Consensus        94 ---------------------------------~yal~~~W~~G~f~C~f~nf~~itav~vSVfTlvAiA~DRy~AIi~P  140 (423)
T KOG4219|consen   94 ---------------------------------QYALHQEWYFGSFYCRFVNFFPITAVFVSVFTLVAIAIDRYMAIIHP  140 (423)
T ss_pred             ---------------------------------HHHHHhccccccceeeeccccchhhhhHhHHHHHHHHHHHHHHHhhh
Confidence                                             33345899999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCccchhhhhHHHHHHHHHHHHHHhhheeEEccCC-----ccccccccCCCcccCcc-----chhhhHHHHHHH
Q psy15368        207 ITAPNLRTPFISKVVSFIAWTASAIFMIPVIMYASIIDSEN-----TKSCNIMWPETENLNGQ-----SAFILYTFILGF  276 (522)
Q Consensus       207 ~~~~~~~t~~~~~~~i~~~Wi~s~~~~~p~~~~~~~~~~~~-----~~~C~~~~~~~~~~~~~-----~~~~~~~~~~~~  276 (522)
                      ++.+  .+++...++++++|++++++++|..+...+.....     ...|...|++.-.....     ..|.....++.+
T Consensus       141 l~~r--~s~r~sk~iIllIW~lA~l~a~P~~l~s~v~~~~~~d~~~~~~~~~~~pe~~~~~~~~~~~~~~y~~vl~~lqY  218 (423)
T KOG4219|consen  141 LQPR--PSRRSSKIIILLIWALALLLALPQLLYSSVEELYLYDGESRVVCVTAWPEHVCPTENESLLMQGYNYVLLFLQY  218 (423)
T ss_pred             cccC--CCCcceeehhHHHHHHHHHHhccceeeeeeEEeeccCCcceEEEEEecccccCCcchhhhhhcceeeeehhHHH
Confidence            9855  79999999999999999999999998876653332     47788888776222222     237888899999


Q ss_pred             HHHHHHHHHHHHHHHHHHHhcCCCCCchhhhccccccceeeeEEeEeeecCCCCCchhhhhhhhhhhhhhHHHHHHHHhh
Q psy15368        277 AIPLVLIFVFYYLVIRKLRTVGPKNKPKEKKKSHRKVTKLVLTVITLRTVGPKNKPKEKKKSHRKVTKLVLTVITVYVLC  356 (522)
Q Consensus       277 ~lp~~ii~~~y~~I~~~lr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~f~i~  356 (522)
                      ++|++++...|..|.+++|..+....++.                         ++.+..+.++|+.||++++++.|.+|
T Consensus       219 flPliVl~~~Yt~iav~LW~~~~~gd~~d-------------------------~~~~~~kak~K~vkmliiVV~~Faic  273 (423)
T KOG4219|consen  219 FLPLIVLGLAYTVIAVTLWGRRIPGDQQD-------------------------RKHEQLKAKKKVVKMLIIVVVIFAIC  273 (423)
T ss_pred             HHHHHHHHHHHHHHHHHHHhccCccchhc-------------------------hhhHHHHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999999999998664333322                         12345577788999999999999999


Q ss_pred             hhhHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHhhccchhHHHHHHcChHHHHHHHHHccccC
Q psy15368        357 WLPYWITQIALIFTPPRQCQSSITVIVFLIAGALSYSNSAMNPILYAFLSDNFKKSFLKACTCAA  421 (522)
Q Consensus       357 ~~P~~i~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~ns~~NPiIY~~~~~~fR~~l~~~~~c~~  421 (522)
                      |+||.+..++....++ -.........+....||++.|+|.||+||++.|++||.++++.++|+.
T Consensus       274 WlPyh~y~il~~~~~~-i~~~k~i~~vyl~~~WLaMSst~yNPiIY~~lN~Rfr~gf~~~fr~cp  337 (423)
T KOG4219|consen  274 WLPYHIYFILNATNPE-INRKKFIQQVYLAIYWLAMSSTCYNPIIYCFLNKRFRGGFRRAFRWCP  337 (423)
T ss_pred             ccChhHHHHHHHhHHH-HHHHHHHHHHHHHHHHHHHHHhhhccHhhhhhHHHHHHHHhhhhheee
Confidence            9999999999876654 233455667888999999999999999999999999999999999886

>PHA03234 DNA packaging protein UL33; Provisional Back     alignment and domain information
>PHA03235 DNA packaging protein UL33; Provisional Back     alignment and domain information
>KOG4220|consensus Back     alignment and domain information
>PHA02834 chemokine receptor-like protein; Provisional Back     alignment and domain information
>PHA02638 CC chemokine receptor-like protein; Provisional Back     alignment and domain information
>PHA03087 G protein-coupled chemokine receptor-like protein; Provisional Back     alignment and domain information
>PF00001 7tm_1: 7 transmembrane receptor (rhodopsin family) Rhodopsin-like GPCR superfamily signature 5-hydroxytryptamine 7 receptor signature bradykinin receptor signature gastrin receptor signature melatonin receptor signature olfactory receptor signature; InterPro: IPR000276 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG2087|consensus Back     alignment and domain information
>PF10324 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemoreceptor Srw; InterPro: IPR019427 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10320 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemoreceptor Srsx; InterPro: IPR019424 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10328 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemoreceptor Srx; InterPro: IPR019430 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10323 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemoreceptor Srv; InterPro: IPR019426 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF05462 Dicty_CAR: Slime mold cyclic AMP receptor Back     alignment and domain information
>PF05296 TAS2R: Mammalian taste receptor protein (TAS2R); InterPro: IPR007960 This family consists of several forms of mammalian taste receptor proteins (TAS2Rs) Back     alignment and domain information
>PF10321 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemoreceptor Srt; InterPro: IPR019425 Chemoreception is mediated in Caenorhabditis elegans by members of the seven-transmembrane G-protein-coupled receptor class (7TM GPCRs) of proteins which are of the serpentine type [] Back     alignment and domain information
>PF10317 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemoreceptor Srd; InterPro: IPR019421 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG4193|consensus Back     alignment and domain information
>PF03402 V1R: Vomeronasal organ pheromone receptor family, V1R; InterPro: IPR004072 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF11710 Git3: G protein-coupled glucose receptor regulating Gpa2; InterPro: IPR023041 This entry contains a functionally uncharacterised region belonging to the Git3 G-protein coupled receptor Back     alignment and domain information
>PF10292 7TM_GPCR_Srab: Serpentine type 7TM GPCR receptor class ab chemoreceptor; InterPro: IPR019408 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF02101 Ocular_alb: Ocular albinism type 1 protein; InterPro: IPR001414 Ocular albinism type 1 (OA1) is an X-linked disorder characterised by severe impairment of visual acuity, retinal hypopigmentation and the presence of macromelanosomes Back     alignment and domain information
>PF02118 Srg: Srg family chemoreceptor; InterPro: IPR000609 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10318 7TM_GPCR_Srh: Serpentine type 7TM GPCR chemoreceptor Srh; InterPro: IPR019422 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10327 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemoreceptor Sri; InterPro: IPR019429 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF10326 7TM_GPCR_Str: Serpentine type 7TM GPCR chemoreceptor Str; InterPro: IPR019428 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG4564|consensus Back     alignment and domain information
>PF10316 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemoreceptor Srbc ; InterPro: IPR019420 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF04789 DUF621: Protein of unknown function (DUF621); InterPro: IPR006874 This is a conserved region found in uncharacterised proteins from Caenorhabditis elegans, and is noted to have possible G-protein-coupled receptor-like activity Back     alignment and domain information
>PF10319 7TM_GPCR_Srj: Serpentine type 7TM GPCR chemoreceptor Srj; InterPro: IPR019423 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF00002 7tm_2: 7 transmembrane receptor (Secretin family); InterPro: IPR000832 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF03125 Sre: C Back     alignment and domain information
>PF02117 7TM_GPCR_Sra: Serpentine type 7TM GPCR chemoreceptor Sra; InterPro: IPR000344 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF01534 Frizzled: Frizzled/Smoothened family membrane region; InterPro: IPR000539 The frizzled (fz) locus of Drosophila coordinates the cytoskeletons of epidermal cells, producing a parallel array of cuticular hairs and bristles [, ] Back     alignment and domain information
>PF10322 7TM_GPCR_Sru: Serpentine type 7TM GPCR chemoreceptor Sru; InterPro: IPR003839 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF11970 Git3_C: G protein-coupled glucose receptor regulating Gpa2 C-term; InterPro: IPR022596 This entry contains a functionally uncharacterised region belonging to the Git3 G-protein coupled receptor Back     alignment and domain information
>KOG4289|consensus Back     alignment and domain information
>PF02076 STE3: Pheromone A receptor; InterPro: IPR001499 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF06681 DUF1182: Protein of unknown function (DUF1182); InterPro: IPR010601 This family consists of several hypothetical proteins of around 360 residues in length and seems to be specific to Caenorhabditis elegans Back     alignment and domain information
>PF03383 Serpentine_r_xa: Caenorhabditis serpentine receptor-like protein, class xa; InterPro: IPR005047 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>PF02175 7TM_GPCR_Srb: Serpentine type 7TM GPCR chemoreceptor Srb; InterPro: IPR002184 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) Back     alignment and domain information
>KOG4220|consensus Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

Original result of BLAST against Protein Data Bank

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query522
4ea3_B434 Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WI 6e-36
4dkl_A464 Crystal Structure Of The Mu-Opioid Receptor Bound T 2e-27
4dkl_A464 Crystal Structure Of The Mu-Opioid Receptor Bound T 2e-05
4djh_A480 Structure Of The Human Kappa Opioid Receptor In Com 4e-27
4djh_A480 Structure Of The Human Kappa Opioid Receptor In Com 3e-05
4ej4_A461 Structure Of The Delta Opioid Receptor Bound To Nal 2e-24
4ej4_A461 Structure Of The Delta Opioid Receptor Bound To Nal 6e-06
3odu_A502 The 2.5 A Structure Of The Cxcr4 Chemokine Receptor 4e-14
3oe6_A508 Crystal Structure Of The Cxcr4 Chemokine Receptor I 5e-14
3oe0_A499 Crystal Structure Of The Cxcr4 Chemokine Receptor I 8e-14
3uon_A467 Structure Of The Human M2 Muscarinic Acetylcholine 5e-10
2y00_B315 Turkey Beta1 Adrenergic Receptor With Stabilising M 1e-09
2vt4_A313 Turkey Beta1 Adrenergic Receptor With Stabilising M 1e-09
3kj6_A366 Crystal Structure Of A Methylated Beta2 Adrenergic 2e-08
3sn6_R514 Crystal Structure Of The Beta2 Adrenergic Receptor- 2e-08
2r4r_A365 Crystal Structure Of The Human Beta2 Adrenoceptor L 3e-08
2r4s_A342 Crystal Structure Of The Human Beta2 Adrenoceptor L 7e-08
4gbr_A309 N-terminal T4 Lysozyme Fusion Facilitates Crystalli 2e-07
2lnl_A296 Structure Of Human Cxcr1 In Phospholipid Bilayers L 3e-07
2x72_A349 Crystal Structure Of The Constitutively Active E113 3e-07
2j4y_A349 Crystal Structure Of A Rhodopsin Stabilizing Mutant 3e-07
3c9m_A348 Structure Of A Mutant Bovine Rhodopsin In Hexagonal 3e-07
4a4m_A349 Crystal Structure Of The Light-Activated Constituti 5e-07
3d4s_A490 Cholesterol Bound Form Of Human Beta2 Adrenergic Re 6e-07
3oax_A349 Crystal Structure Of Bovine Rhodopsin With Beta-Ion 7e-07
1jfp_A348 Structure Of Bovine Rhodopsin (Dark Adapted) Length 7e-07
3p0g_A501 Structure Of A Nanobody-Stabilized Active State Of 1e-06
2rh1_A500 High Resolution Crystal Structure Of Human B2-Adren 1e-06
3rze_A452 Structure Of The Human Histamine H1 Receptor In Com 1e-06
3rze_A452 Structure Of The Human Histamine H1 Receptor In Com 6e-04
2z73_A448 Crystal Structure Of Squid Rhodopsin Length = 448 2e-06
2ziy_A372 Crystal Structure Of Squid Rhodopsin Length = 372 2e-06
2ks9_A364 Solution Conformation Of Substance P In Water Compl 2e-06
4daj_A479 Structure Of The M3 Muscarinic Acetylcholine Recept 3e-06
3pds_A458 Irreversible Agonist-Beta2 Adrenoceptor Complex Len 3e-06
3vw7_A484 Crystal Structure Of Human Protease-Activated Recep 4e-06
4grv_A510 The Crystal Structure Of The Neurotensin Receptor N 6e-06
2ydo_A325 Thermostabilised Human A2a Receptor With Adenosine 3e-04
3pbl_A481 Structure Of The Human Dopamine D3 Receptor In Comp 4e-04
>pdb|4EA3|B Chain B, Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WITH A PEPTIDE Mimetic Length = 434 Back     alignment and structure 
Iteration: 1

 Score =  148 bits (374), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 107/362 (29%), Positives = 162/362 (44%), Gaps = 80/362 (22%)
Query: 60  IYLIICITGLLGNTLVIYVVLRFSKMQTVTNMYIVNLAIADECFLIGIPFLMITIKMQTV 119
           +YL +C+ GLLGN LV+YV+LR +KM+T T                              
Sbjct: 131 LYLAVCVGGLLGNCLVMYVILRHTKMKTAT------------------------------ 160
Query: 120 TNMYIVNLAIADECFLIGIPFLMITMSISYWHYILVSLFRVASLSSYWPFGDLMCKIYMT 179
            N+YI NLA+AD   L+ +PF    +                 L  +WPFG+ +CK  + 
Sbjct: 161 -NIYIFNLALADTLVLLTLPFQGTDI-----------------LLGFWPFGNALCKTVIA 202
Query: 180 TTSINQFTSSIFLTIMSADRYVAVCHPITAPNLRTPFISKVVSFIAWTASAIFMIPVIMY 239
               N FTS+  LT MS DRYVA+CHPI A ++RT   ++ V+   W  +++  +PV + 
Sbjct: 203 IDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIM 262
Query: 240 ASIIDSENTKSCNIMWPETENLNGQSAFILYTFILGFAIPLVLIFVFYYLVIRKLRTVGP 299
            S    +    C +  P  ++  G   F +  F+  F +P+++I V Y L+IR+LR V  
Sbjct: 263 GSAQVEDEEIECLVEIPTPQDYWG-PVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRL 321
Query: 300 XXXXXXXXXXXXXVTKLVLTVITLRTVGPXXXXXXXXXXXXXXXXXXXXXXXXXXXCWLP 359
                        +T+LVL V+ +                                CW P
Sbjct: 322 LSGSREKDRNLRRITRLVLVVVAVFV-----------------------------GCWTP 352
Query: 360 YWITQIALIFTPPRQCQSSITVIVFLIAGALSYSNSAMNPILYAFLSDNFKKSFLKACTC 419
             +  +A         ++++ ++ F    AL Y NS +NPILYAFL +NFK  F K C  
Sbjct: 353 VQVFVLAQGLGVQPSSETAVAILRFCT--ALGYVNSCLNPILYAFLDENFKACFRKFCCA 410
Query: 420 AA 421
           +A
Sbjct: 411 SA 412
>pdb|4DKL|A Chain A, Crystal Structure Of The Mu-Opioid Receptor Bound To A Morphinan Antagonist Length = 464 Back     alignment and structure
>pdb|4DKL|A Chain A, Crystal Structure Of The Mu-Opioid Receptor Bound To A Morphinan Antagonist Length = 464 Back     alignment and structure
>pdb|4DJH|A Chain A, Structure Of The Human Kappa Opioid Receptor In Complex With Jdtic Length = 480 Back     alignment and structure
>pdb|4DJH|A Chain A, Structure Of The Human Kappa Opioid Receptor In Complex With Jdtic Length = 480 Back     alignment and structure
>pdb|4EJ4|A Chain A, Structure Of The Delta Opioid Receptor Bound To Naltrindole Length = 461 Back     alignment and structure
>pdb|4EJ4|A Chain A, Structure Of The Delta Opioid Receptor Bound To Naltrindole Length = 461 Back     alignment and structure
>pdb|3ODU|A Chain A, The 2.5 A Structure Of The Cxcr4 Chemokine Receptor In Complex With Small Molecule Antagonist It1t Length = 502 Back     alignment and structure
>pdb|3OE6|A Chain A, Crystal Structure Of The Cxcr4 Chemokine Receptor In Complex With A Small Molecule Antagonist It1t In I222 Spacegroup Length = 508 Back     alignment and structure
>pdb|3OE0|A Chain A, Crystal Structure Of The Cxcr4 Chemokine Receptor In Complex With A Cyclic Peptide Antagonist Cvx15 Length = 499 Back     alignment and structure
>pdb|3UON|A Chain A, Structure Of The Human M2 Muscarinic Acetylcholine Receptor Bound To An Antagonist Length = 467 Back     alignment and structure
>pdb|2Y00|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Partial Agonist Dobutamine (Crystal Dob92) Length = 315 Back     alignment and structure
>pdb|2VT4|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Cyanopindolol Length = 313 Back     alignment and structure
>pdb|3KJ6|A Chain A, Crystal Structure Of A Methylated Beta2 Adrenergic Receptor- Fab Complex Length = 366 Back     alignment and structure
>pdb|3SN6|R Chain R, Crystal Structure Of The Beta2 Adrenergic Receptor-Gs Protein Complex Length = 514 Back     alignment and structure
>pdb|2R4R|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 365 Back     alignment and structure
>pdb|2R4S|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 342 Back     alignment and structure
>pdb|4GBR|A Chain A, N-terminal T4 Lysozyme Fusion Facilitates Crystallization Of A G Protein Coupled Receptor Length = 309 Back     alignment and structure
>pdb|2LNL|A Chain A, Structure Of Human Cxcr1 In Phospholipid Bilayers Length = 296 Back     alignment and structure
>pdb|2X72|A Chain A, Crystal Structure Of The Constitutively Active E113q,N2c, D282c Rhodopsin Mutant With Bound Galphact Peptide Length = 349 Back     alignment and structure
>pdb|2J4Y|A Chain A, Crystal Structure Of A Rhodopsin Stabilizing Mutant Expressed In Mammalian Cells Length = 349 Back     alignment and structure
>pdb|3C9M|A Chain A, Structure Of A Mutant Bovine Rhodopsin In Hexagonal Crystal Form Length = 348 Back     alignment and structure
>pdb|4A4M|A Chain A, Crystal Structure Of The Light-Activated Constitutively Active N2c,M257y,D282c Rhodopsin Mutant In Complex With A Peptide Resembling The C-Terminus Of The Galpha-Protein Subunit (Gact) Length = 349 Back     alignment and structure
>pdb|3D4S|A Chain A, Cholesterol Bound Form Of Human Beta2 Adrenergic Receptor. Length = 490 Back     alignment and structure
>pdb|3OAX|A Chain A, Crystal Structure Of Bovine Rhodopsin With Beta-Ionone Length = 349 Back     alignment and structure
>pdb|1JFP|A Chain A, Structure Of Bovine Rhodopsin (Dark Adapted) Length = 348 Back     alignment and structure
>pdb|3P0G|A Chain A, Structure Of A Nanobody-Stabilized Active State Of The Beta2 Adrenoceptor Length = 501 Back     alignment and structure
>pdb|2RH1|A Chain A, High Resolution Crystal Structure Of Human B2-Adrenergic G Protein- Coupled Receptor Length = 500 Back     alignment and structure
>pdb|3RZE|A Chain A, Structure Of The Human Histamine H1 Receptor In Complex With Doxepin Length = 452 Back     alignment and structure
>pdb|3RZE|A Chain A, Structure Of The Human Histamine H1 Receptor In Complex With Doxepin Length = 452 Back     alignment and structure
>pdb|2Z73|A Chain A, Crystal Structure Of Squid Rhodopsin Length = 448 Back     alignment and structure
>pdb|2ZIY|A Chain A, Crystal Structure Of Squid Rhodopsin Length = 372 Back     alignment and structure
>pdb|2KS9|A Chain A, Solution Conformation Of Substance P In Water Complexed With Nk1r Length = 364 Back     alignment and structure
>pdb|4DAJ|A Chain A, Structure Of The M3 Muscarinic Acetylcholine Receptor Length = 479 Back     alignment and structure
>pdb|3PDS|A Chain A, Irreversible Agonist-Beta2 Adrenoceptor Complex Length = 458 Back     alignment and structure
>pdb|3VW7|A Chain A, Crystal Structure Of Human Protease-Activated Receptor 1 (Par1) Bound With Antagonist Vorapaxar At 2.2 Angstrom Length = 484 Back     alignment and structure
>pdb|4GRV|A Chain A, The Crystal Structure Of The Neurotensin Receptor Nts1 In Complex With Neurotensin (8-13) Length = 510 Back     alignment and structure
>pdb|2YDO|A Chain A, Thermostabilised Human A2a Receptor With Adenosine Bound Length = 325 Back     alignment and structure
>pdb|3PBL|A Chain A, Structure Of The Human Dopamine D3 Receptor In Complex With Eticlopride Length = 481 Back     alignment and structure

Structure Templates Detected by RPS-BLAST ?

Original result of RPS-BLAST against PDB70 database

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query522
4ea3_A434 Fusion protein of nociceptin receptor and cytochr; 1e-102
2ks9_A364 Substance-P receptor; water, autodock, NK1, neurop 8e-94
1u19_A349 Rhodopsin; G protein-coupled receptor, membrane pr 2e-70
2z73_A448 Rhodopsin; visual pigment, GQ-type, G-protein coup 2e-66
4dkl_A464 MU-type opioid receptor, lysozyme chimera; G-prote 5e-66
4dkl_A464 MU-type opioid receptor, lysozyme chimera; G-prote 1e-21
3odu_A502 C-X-C chemokine receptor type 4, lysozyme chimera; 2e-62
3odu_A502 C-X-C chemokine receptor type 4, lysozyme chimera; 3e-19
3sn6_R514 Lysozyme, beta-2 adrenergic receptor; seven transm 1e-49
4amj_A315 Beta-1 adrenergic receptor; membrane protein, 7TMR 5e-44
3eml_A488 Human adenosine A2A receptor/T4 lysozyme chimera; 5e-31
3eml_A488 Human adenosine A2A receptor/T4 lysozyme chimera; 1e-14
2rh1_A500 Beta-2-adrenergic receptor/T4-lysozyme chimera; GP 1e-30
2rh1_A500 Beta-2-adrenergic receptor/T4-lysozyme chimera; GP 1e-11
3rze_A452 Histamine H1 receptor, lysozyme chimera; structura 1e-29
3rze_A452 Histamine H1 receptor, lysozyme chimera; structura 3e-13
3uon_A467 Human M2 muscarinic acetylcholine, receptor T4 LY 2e-29
3uon_A467 Human M2 muscarinic acetylcholine, receptor T4 LY 1e-12
4eiy_A447 Adenosine receptor A2A/soluble cytochrome B562 CH; 5e-28
4eiy_A447 Adenosine receptor A2A/soluble cytochrome B562 CH; 8e-11
3pbl_A481 D(3) dopamine receptor, lysozyme chimera; structur 9e-27
3pbl_A481 D(3) dopamine receptor, lysozyme chimera; structur 2e-11
3v2y_A520 Sphingosine 1-phosphate receptor 1, lysozyme CHIM; 1e-20
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 1e-04
>2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Length = 364 Back     alignment and structure
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Length = 349 Back     alignment and structure
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 Back     alignment and structure
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 Back     alignment and structure
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 Back     alignment and structure
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Length = 502 Back     alignment and structure
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Length = 502 Back     alignment and structure
>3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A Length = 514 Back     alignment and structure
>4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Length = 315 Back     alignment and structure
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 Back     alignment and structure
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 Back     alignment and structure
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 Back     alignment and structure
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 Back     alignment and structure
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 Back     alignment and structure
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 Back     alignment and structure
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 Back     alignment and structure
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 Back     alignment and structure
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 Back     alignment and structure
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 Back     alignment and structure
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 Back     alignment and structure
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 Back     alignment and structure
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure

Structure Templates Detected by HHsearch ?

Original result of HHsearch against PDB70 database

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query522
4grv_A510 Neurotensin receptor type 1, lysozyme chimera; G-p 100.0
2ks9_A364 Substance-P receptor; water, autodock, NK1, neurop 100.0
3vw7_A484 Proteinase-activated receptor 1, lysozyme; high re 100.0
2rh1_A500 Beta-2-adrenergic receptor/T4-lysozyme chimera; GP 100.0
3odu_A502 C-X-C chemokine receptor type 4, lysozyme chimera; 100.0
1u19_A349 Rhodopsin; G protein-coupled receptor, membrane pr 100.0
4dkl_A464 MU-type opioid receptor, lysozyme chimera; G-prote 100.0
3uon_A467 Human M2 muscarinic acetylcholine, receptor T4 LY 100.0
2lnl_A296 C-X-C chemokine receptor type 1; G protein coupled 100.0
4ea3_A434 Fusion protein of nociceptin receptor and cytochr; 100.0
3eml_A488 Human adenosine A2A receptor/T4 lysozyme chimera; 100.0
3v2y_A520 Sphingosine 1-phosphate receptor 1, lysozyme CHIM; 100.0
3pbl_A481 D(3) dopamine receptor, lysozyme chimera; structur 100.0
3rze_A452 Histamine H1 receptor, lysozyme chimera; structura 100.0
4amj_A315 Beta-1 adrenergic receptor; membrane protein, 7TMR 100.0
2z73_A448 Rhodopsin; visual pigment, GQ-type, G-protein coup 100.0
4eiy_A447 Adenosine receptor A2A/soluble cytochrome B562 CH; 100.0
3sn6_R514 Lysozyme, beta-2 adrenergic receptor; seven transm 100.0
2koe_A40 Human cannabinoid receptor 1 - helix 7/8 peptide; 98.51
1hll_A32 Alpha-2A adrenergic receptor; helix-linker-helix, 98.47
2ki9_A33 Cannabinoid receptor 2; GPCR, G-protein coupled re 97.78
2lot_A64 Apelin receptor; membrane protein; NMR {Homo sapie 97.01
2ks9_A364 Substance-P receptor; water, autodock, NK1, neurop 95.08
4ea3_A434 Fusion protein of nociceptin receptor and cytochr; 94.77
1u19_A349 Rhodopsin; G protein-coupled receptor, membrane pr 84.38
>4grv_A Neurotensin receptor type 1, lysozyme chimera; G-protein coupled receptor, G-protein, signaling protein-agonist complex; HET: EPE; 2.80A {Rattus norvegicus} Back     alignment and structure
Probab=100.00  E-value=6.8e-48  Score=400.77  Aligned_cols=324  Identities=22%  Similarity=0.424  Sum_probs=232.1

Q ss_pred             CCchHHHHHHHHHHHHHHHhhhhHHHHHHhhhccccc---cchhhHHHHHhhhhhhhhh-ccchhheehhhccchhhhhh
Q psy15368         50 GPTLFFATQTIYLIICITGLLGNTLVIYVVLRFSKMQ---TVTNMYIVNLAIADECFLI-GIPFLMITIKMQTVTNMYIV  125 (522)
Q Consensus        50 ~~~~~~~~~~i~~ii~~~giigN~lvi~vi~~~~~lr---~~~~~~l~~LaiaDll~~l-~~p~~~~~~~~~~~~~~~~~  125 (522)
                      +....++..+++.+++++|++||+++++++.++|++|   +++|+|++|||+||+++++ ++|+.+...           
T Consensus        28 ~~~~~v~~~~~~~~i~~~g~~gN~lvi~~i~~~~~~r~~~~~~n~~i~~La~aDll~~~~~~p~~~~~~-----------   96 (510)
T 4grv_A           28 DIYSKVLVTAIYLALFVVGTVGNSVTLFTLARKKSLQSLQSTVHYHLGSLALSDLLILLLAMPVELYNF-----------   96 (510)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHHHHHHHTSCC----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHT-----------
T ss_pred             hHHHHHHHHHHHHHHHHHHHHHHHHhhhheeeecCCCCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHH-----------
Confidence            4456778889999999999999999999998877655   6789999999999999754 667665211           


Q ss_pred             hhhhhhhhhhhcccceeeehhhhhhhHHhhhHhhhcccCCccccccccchhhhhhhhHHHHHHHHHHHHHHHHHHHHhhh
Q psy15368        126 NLAIADECFLIGIPFLMITMSISYWHYILVSLFRVASLSSYWPFGDLMCKIYMTTTSINQFTSSIFLTIMSADRYVAVCH  205 (522)
Q Consensus       126 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~~~~~~s~~~l~~isidRy~aI~~  205 (522)
                                                         ....+.|.+|+.+|++..++..++..+|++++++||+|||+||++
T Consensus        97 -----------------------------------~~~~~~w~~g~~~C~~~~~~~~~~~~~S~~~l~~is~dRy~ai~~  141 (510)
T 4grv_A           97 -----------------------------------IWVHHPWAFGDAGCRGYYFLRDACTYATALNVASLSVARYLAICH  141 (510)
T ss_dssp             -----------------------------------TTCCSSCSSHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred             -----------------------------------HHhCCCEEhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHheEEEec
Confidence                                               112467999999999999999999999999999999999999999


Q ss_pred             cCCCCCCCCccchhhhhHHHHHHHHHHHHHHhhheeEEccCC------ccccccccCCCcccCccchhhhHHHHHHHHHH
Q psy15368        206 PITAPNLRTPFISKVVSFIAWTASAIFMIPVIMYASIIDSEN------TKSCNIMWPETENLNGQSAFILYTFILGFAIP  279 (522)
Q Consensus       206 P~~~~~~~t~~~~~~~i~~~Wi~s~~~~~p~~~~~~~~~~~~------~~~C~~~~~~~~~~~~~~~~~~~~~~~~~~lp  279 (522)
                      |++|+..++++++.++++++|++++++++|.++.........      ...|...+...    ....|..+..++.+++|
T Consensus       142 P~~~~~~~t~~~~~~~i~~~W~~s~~~~~p~~~~~~~~~~~~~~~~~~~~~c~~~~~~~----~~~~~~~~~~~~~f~iP  217 (510)
T 4grv_A          142 PFKAKTLMSRSRTKKFISAIWLASALLAIPMLFTMGLQNRSADGTHPGGLVCTPIVDTA----TVKVVIQVNTFMSFLFP  217 (510)
T ss_dssp             CCCCCCCCCCSCCHHHHHHHHHHHHHHHTTHHHHEEEEECSSSSCCGGGEEEEECSCHH----HHHHHHHHHHHHHTHHH
T ss_pred             cccccccccccccceeehHHHHHHHHHHHHHHHhhcccccccCCCCCCccccccccccc----hhhhhhhhhhhHHHhhh
Confidence            999999999999999999999999999999888776543322      13355444322    24467777788889999


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCCchhhhccccccc-----e-eeeE--------------------EeE-----------
Q psy15368        280 LVLIFVFYYLVIRKLRTVGPKNKPKEKKKSHRKVT-----K-LVLT--------------------VIT-----------  322 (522)
Q Consensus       280 ~~ii~~~y~~I~~~lr~~~~~~~~~~~~~~~~~~~-----~-~~~~--------------------~~~-----------  322 (522)
                      +++|+++|.+|++.++++.+.....+.....+...     . ....                    ...           
T Consensus       218 ~~ii~~~Y~~I~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (510)
T 4grv_A          218 MLVISILNTVIANKLTVMVNIFEMLRIDEGLRLKIYKDTEGYYTIGIGHLLTKSPSLNAAKSELDKAIGRNTNGVITKDE  297 (510)
T ss_dssp             HHHHHHHHHHHHHHHHTSCTHHHHHHHHTCCEEEEEECTTSCEEEETTEECCCSSSHHHHHHSCCC---CCCTTBCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhhhhhhhccccccccccccccccccccccccccCCCCCCCccccccCcCCCCCCCCcccCCc
Confidence            99999999999999987654322111100000000     0 0000                    000           


Q ss_pred             --------------------------------------------------------------------------------
Q psy15368        323 --------------------------------------------------------------------------------  322 (522)
Q Consensus       323 --------------------------------------------------------------------------------  322 (522)
                                                                                                      
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (510)
T 4grv_A          298 AEKLFNQDVDAAVRGILRNAKLKPVYDSLDAVRRAALINMVFQMGETGVAGFTNSLRMLNNKRWDEAAVNLAKSRWYNQT  377 (510)
T ss_dssp             HHHHHHHHHHHHHHHHHHCTTTHHHHHHSCSHHHHHHHHHHHHHHHHHHTTCHHHHHHHTTTCHHHHHHHHHSSCSCCSS
T ss_pred             cccccCCCCcccccccccCCCCCCCcCccccccccccCCccccCCCCCCCCCCccccccccCCCcccccccccccccccC
Confidence                                                                                            


Q ss_pred             ----------eeecCCCCCchhhhhhhhhhhhhhHHHHHHHHhhhhhHHHHHHHHHhcCCCCCCC---chhHHHHHHHHH
Q psy15368        323 ----------LRTVGPKNKPKEKKKSHRKVTKLVLTVITVYVLCWLPYWITQIALIFTPPRQCQS---SITVIVFLIAGA  389 (522)
Q Consensus       323 ----------~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~f~i~~~P~~i~~i~~~~~~~~~~~~---~~~~~~~~~~~~  389 (522)
                                .+........++..++|+|++||+++++++|++||+||++..++..+.++.....   ....++..++.+
T Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~erk~~k~L~iVv~~F~iCWlPf~i~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (510)
T 4grv_A          378 PNRAKRVITTFRTGTWDAYGSGSVQALRHGVLVARAVVIAFVVCWLPYHVRRLMFCYISDEQWTTFLFDFYHYFYMLTNA  457 (510)
T ss_dssp             HHHHHHHHHHHHHSSSGGGTTSTTTHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTTTCCCHHHHHHHHHHHHHHHH
T ss_pred             CccccccccccccccchhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCcccCChhHHHHHHHHHHHHHH
Confidence                      0000000111233467889999999999999999999999999988876533222   233456778899


Q ss_pred             HHhhccchhHHHHHHcChHHHHHHHHHccccCCC
Q psy15368        390 LSYSNSAMNPILYAFLSDNFKKSFLKACTCAAGK  423 (522)
Q Consensus       390 l~~~ns~~NPiIY~~~~~~fR~~l~~~~~c~~~~  423 (522)
                      |+++||++||+||+++|++||++++++++|++.+
T Consensus       458 L~Y~NS~iNPiIY~~~n~~FR~aFk~iL~C~C~~  491 (510)
T 4grv_A          458 LAYASSAINPILYNLVSANFRQVFLSTLACLCPG  491 (510)
T ss_dssp             HHHHHHHHHHHHHHHHHSCCCCC-----------
T ss_pred             HHHHHHHHHHHHHHhcCHHHHHHHHHHHhhcCCC
Confidence            9999999999999999999999999999877643
>2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Back     alignment and structure
>3vw7_A Proteinase-activated receptor 1, lysozyme; high resolution structure, protease-activated receptor 1, in conformation, antagonist vorapaxar; HET: VPX OLC; 2.20A {Homo sapiens} Back     alignment and structure
>2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Back     alignment and structure
>3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Back     alignment and structure
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Back     alignment and structure
>4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Back     alignment and structure
>3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Back     alignment and structure
>2lnl_A C-X-C chemokine receptor type 1; G protein coupled receptor, GPCR, membrane protei transmembrane, 7TM, phospholipid, signaling, signaling PROT; NMR {Homo sapiens} Back     alignment and structure
>3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Back     alignment and structure
>3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Back     alignment and structure
>3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, PSI-biology, protein structure initiative; HET: ETQ MAL; 2.89A {Homo sapiens} Back     alignment and structure
>3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Back     alignment and structure
>4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Back     alignment and structure
>2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Back     alignment and structure
>4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Back     alignment and structure
>3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A 4gbr_A* Back     alignment and structure
>2koe_A Human cannabinoid receptor 1 - helix 7/8 peptide; GPCR, HCB1, membrane protein, signaling protein; NMR {Homo sapiens} Back     alignment and structure
>1hll_A Alpha-2A adrenergic receptor; helix-linker-helix, membrane protein; NMR {Synthetic} SCOP: j.94.1.1 PDB: 1hof_A 1ho9_A 1hod_A Back     alignment and structure
>2ki9_A Cannabinoid receptor 2; GPCR, G-protein coupled receptor, membrane protein; NMR {Synthetic} Back     alignment and structure
>2lot_A Apelin receptor; membrane protein; NMR {Homo sapiens} PDB: 2lou_A 2lov_A 2low_A Back     alignment and structure
>2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Back     alignment and structure
>1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

Original result of RPS-BLAST against SCOP70(version1.75) database

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 522
d1u19a_348 f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 1e-28
>d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Length = 348 Back     information, alignment and structure

class: Membrane and cell surface proteins and peptides
fold: Family A G protein-coupled receptor-like
superfamily: Family A G protein-coupled receptor-like
family: Rhodopsin-like
domain: Rhodopsin
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  114 bits (285), Expect = 1e-28
 Identities = 63/373 (16%), Positives = 131/373 (35%), Gaps = 79/373 (21%)

Query: 47  HSTGPTLFFATQTIYLIICITGLLGNTLVIYVVLRFSKMQTVTNMYIVNLAIADECFLIG 106
           +   P  F        ++ + G   N L +YV ++  K++T  N  ++NLA+AD   + G
Sbjct: 30  YLAEPWQFSMLAAYMFLLIMLGFPINFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVFG 89

Query: 107 IPFLMITIKMQTVTNMYIVNLAIADECFLIGIPFLMITMSISYWHYILVSLFRVASLSSY 166
                +   +                                                 Y
Sbjct: 90  GFTTTLYTSLH-----------------------------------------------GY 102

Query: 167 WPFGDLMCKIYMTTTSINQFTSSIFLTIMSADRYVAVCHPITAPNLRTPFISKVVSFIAW 226
           + FG   C +     ++    +   L +++ +RYV VC P++            V+F   
Sbjct: 103 FVFGPTGCNLEGFFATLGGEIALWSLVVLAIERYVVVCKPMSNFRFGENHAIMGVAFTWV 162

Query: 227 TASAIFMIPVIMYASIIDSENTKSCNIMWPETENLNGQSAFILYTFILGFAIPLVLIFVF 286
            A A    P++ ++  I      SC I +          +F++Y F++ F IPL++IF  
Sbjct: 163 MALACAAPPLVGWSRYIPEGMQCSCGIDYYTPHEETNNESFVIYMFVVHFIIPLIVIFFC 222

Query: 287 YYLVIRKLRTVGPKNKPKEKKKSHRKVTKLVLTVITLRTVGPKNKPKEKKKSHRKVTKLV 346
           Y  ++  ++    +                              +    +K+ ++VT++V
Sbjct: 223 YGQLVFTVKEAAAQQ----------------------------QESATTQKAEKEVTRMV 254

Query: 347 LTVITVYVLCWLPYWITQIALIFTPPRQCQSSITVIVFLIAGALSYSNSAMNPILYAFLS 406
           + ++  +++CWLPY      +         S    I   I    + +++  NP++Y  ++
Sbjct: 255 IIMVIAFLICWLPYAGVAFYIFTHQG----SDFGPIFMTIPAFFAKTSAVYNPVIYIMMN 310

Query: 407 DNFKKSFLKACTC 419
             F+   +    C
Sbjct: 311 KQFRNCMVTTLCC 323

Homologous Domains Detected by HHsearch ?

Original result of HHsearch against SCOP70(version1.75) database

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query522
d1u19a_348 Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} 100.0
d1u19a_348 Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} 96.05
>d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
class: Membrane and cell surface proteins and peptides
fold: Family A G protein-coupled receptor-like
superfamily: Family A G protein-coupled receptor-like
family: Rhodopsin-like
domain: Rhodopsin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.1e-39  Score=320.06  Aligned_cols=295  Identities=21%  Similarity=0.445  Sum_probs=235.5

Q ss_pred             CCCchHHHHHHHHHHHHHHHhhhhHHHHHHhhhccccccchhhHHHHHhhhhhhhhhc-cchhheehhhccchhhhhhhh
Q psy15368         49 TGPTLFFATQTIYLIICITGLLGNTLVIYVVLRFSKMQTVTNMYIVNLAIADECFLIG-IPFLMITIKMQTVTNMYIVNL  127 (522)
Q Consensus        49 ~~~~~~~~~~~i~~ii~~~giigN~lvi~vi~~~~~lr~~~~~~l~~LaiaDll~~l~-~p~~~~~~~~~~~~~~~~~~~  127 (522)
                      .+++...+.++++.+++++|++||+++++++.++|++|++.|++++|||++|++.++. .|..+                
T Consensus        32 ~~~~~~~~~~~~~~ii~v~gi~gN~lvi~vi~~~k~lr~~~~~~l~nLaiaDll~~~~~~~~~~----------------   95 (348)
T d1u19a_          32 AEPWQFSMLAAYMFLLIMLGFPINFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTL----------------   95 (348)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSTTCCSHHHHHHHHHHHHHHHHHHHTHHHHH----------------
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHHHHHeehhhhccCCCCCHhHHHHHHHHHHHHHHHHHHHHHhh----------------
Confidence            3455677889999999999999999999999999999999999999999999997654 44433                


Q ss_pred             hhhhhhhhhcccceeeehhhhhhhHHhhhHhhhcccCCccccccccchhhhhhhhHHHHHHHHHHHHHHHHHHHHhhhcC
Q psy15368        128 AIADECFLIGIPFLMITMSISYWHYILVSLFRVASLSSYWPFGDLMCKIYMTTTSINQFTSSIFLTIMSADRYVAVCHPI  207 (522)
Q Consensus       128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~~~~~~~s~~~l~~isidRy~aI~~P~  207 (522)
                                                      .....+.|..+...|+...++...+..+++++++++++|||++|++|+
T Consensus        96 --------------------------------~~~~~~~~~~~~~~c~~~~~~~~~~~~~s~~~l~~is~~R~~~i~~p~  143 (348)
T d1u19a_          96 --------------------------------YTSLHGYFVFGPTGCNLEGFFATLGGEIALWSLVVLAIERYVVVCKPM  143 (348)
T ss_dssp             --------------------------------HHHHHTSCTTHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTCCS
T ss_pred             --------------------------------hhhccCccccCchhhhhhhhccccceeeecchhhhhhcccceeeeccc
Confidence                                            111236688889999999999999999999999999999999999999


Q ss_pred             CCCCCCCccchhhhhHHHHHHHHHHHHHHhhh-eeEEccCCccccccccCCCcccCccchhhhHHHHHHHHHHHHHHHHH
Q psy15368        208 TAPNLRTPFISKVVSFIAWTASAIFMIPVIMY-ASIIDSENTKSCNIMWPETENLNGQSAFILYTFILGFAIPLVLIFVF  286 (522)
Q Consensus       208 ~~~~~~t~~~~~~~i~~~Wi~s~~~~~p~~~~-~~~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~ii~~~  286 (522)
                      +|+.. ++++....++.+|.+++++..|..+. ...........|...+...........+..+...+.+++|++++.++
T Consensus       144 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~i~~~~  222 (348)
T d1u19a_         144 SNFRF-GENHAIMGVAFTWVMALACAAPPLVGWSRYIPEGMQCSCGIDYYTPHEETNNESFVIYMFVVHFIIPLIVIFFC  222 (348)
T ss_dssp             SSCCC-CHHHHHHHHHHHHHHHHHHHSGGGTTSSCCEEETTTTEEECCCSCCCGGGTHHHHHHHHHHHTTHHHHHHHHHH
T ss_pred             ccccc-ccccccccceeeehhhhheecccccccceeccCCcccccccccccccccccchhhHHHHHHHHHHHHHHHHHHH
Confidence            98776 55666777777788888877665544 33344444455665555544444556677778888889999999999


Q ss_pred             HHHHHHHHHhcCCCCCchhhhccccccceeeeEEeEeeecCCCCCchhhhhhhhhhhhhhHHHHHHHHhhhhhHHHHHHH
Q psy15368        287 YYLVIRKLRTVGPKNKPKEKKKSHRKVTKLVLTVITLRTVGPKNKPKEKKKSHRKVTKLVLTVITVYVLCWLPYWITQIA  366 (522)
Q Consensus       287 y~~I~~~lr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~f~i~~~P~~i~~i~  366 (522)
                      |.++.+++|++.++.+..                            .++.++++|.+|++++++++|++||+|+.+..++
T Consensus       223 y~~i~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~i~~~f~~~~~P~~i~~~~  274 (348)
T d1u19a_         223 YGQLVFTVKEAAAQQQES----------------------------ATTQKAEKEVTRMVIIMVIAFLICWLPYAGVAFY  274 (348)
T ss_dssp             HTTTTTSSCSCCCSSCSS----------------------------SHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHhhhcccccccchh----------------------------hhhHHHHhhHhheEEEeehHHHHHhhHHHhhhhe
Confidence            999988887655443322                            2345778999999999999999999999998887


Q ss_pred             HHhcCCCCCCCchhHHHHHHHHHHHhhccchhHHHHHHcChHHHHHHHHHccccCCCC
Q psy15368        367 LIFTPPRQCQSSITVIVFLIAGALSYSNSAMNPILYAFLSDNFKKSFLKACTCAAGKD  424 (522)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~l~~~ns~~NPiIY~~~~~~fR~~l~~~~~c~~~~~  424 (522)
                      ....+...    ....+..+..++.++|+++||+||++++++||++++++++|++++.
T Consensus       275 ~~~~~~~~----~~~~~~~~~~~l~~~ns~iNPiIY~~~~~~fR~~~~~~l~c~~~~~  328 (348)
T d1u19a_         275 IFTHQGSD----FGPIFMTIPAFFAKTSAVYNPVIYIMMNKQFRNCMVTTLCCGKNPL  328 (348)
T ss_dssp             HHHTTTSC----CCHHHHHHHHHHGGGGGTHHHHHHHHTCHHHHHHHHHHHTSSCCCT
T ss_pred             eeccCCcc----ccHHHHHHHHHHHHHHHHHHHHHHHhcCHHHHHHHHHHhCCCCCCC
Confidence            77665422    2345677888999999999999999999999999999998776544
>d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure